0001140361-15-014791.txt : 20150408 0001140361-15-014791.hdr.sgml : 20150408 20150408173123 ACCESSION NUMBER: 0001140361-15-014791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150406 FILED AS OF DATE: 20150408 DATE AS OF CHANGE: 20150408 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARDELYX, INC. CENTRAL INDEX KEY: 0001437402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-7047 MAIL ADDRESS: STREET 1: 34175 ARDENWOOD BLVD. CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: NTERYX INC DATE OF NAME CHANGE: 20080611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaufmann Mark CENTRAL INDEX KEY: 0001611184 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36485 FILM NUMBER: 15759852 MAIL ADDRESS: STREET 1: C/O ARDELYX, INC. STREET 2: 34175 ARDENWOOD BLVD, SUITE 100 CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc1.xml FORM 4 X0306 4 2015-04-06 0 0001437402 ARDELYX, INC. ARDX 0001611184 Kaufmann Mark C/O ARDELYX, INC. 34175 ARDENWOOD BLVD, SUITE 200 FREMONT CA 94555 0 1 0 0 Chief Financial Officer Common Stock 2015-04-06 4 M 0 7681 0.54 A 8277 D Common Stock 2015-04-06 4 S 0 7681 12.8018 D 596 D Stock Option (Right to Buy) 0.54 2015-04-06 4 M 0 7681 0.00 D 2021-08-11 Common Stock 7681 129977 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 26, 2014. This transaction was executed in multiple trades in prices ranging from $12.59 to $13.07, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The option is immediately exercisable in full, but the shares subject thereto vest according to the following schedule: Twenty-five percent (25%) of the shares subject to the option vest on the first anniversary measured from September 1, 2011, and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. /s/ Elizabeth Grammer, Attorney-in-Fact for Mark Kaufmann 2015-04-08